This clinical trial result is impressive. Antiepileptic is the pharmaceutical world is one of the most costly medicines sold in huge volume.
"Satipharm’s CBD capsules significantly reduced monthly seizure frequency in the treatment-resistant children when added to current medications. The median reduction was -82% in the 12-week treatment period compared to the 4-week observation period. "
82 % reduction of seizure from "Patients were eligible to participate if they were between 2 and 15 years old, had tried at least four prior anti-epileptic drugs (AEDs), including one trial of a combination of two AEDs, without successful seizure control."
Our capsules didn't only reduce seizure but reduced seizure children suffering from refractory, or treatment-resistant epilepsy.
Many people with this type of seizure die in very early age and impossible to have a healthy life.
Stage 3 clinical trial takes place in worldwide and this is a stage where we can see some cash flowing in as well. As we sell rights to trial in various countries. Satipharm is only a licenced producer, phytotech reserves full rights over capsules.
I will have to say no to selling phytotech to harvest one. Eight mil is an absolute rip off.
MMJ Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
